# Hongyu Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/hongyu-medical

- Industry: Medical Devices & Equipment
- Headquarters: Shanghai, China
- Total disclosed funding: $4.2M
- Latest round: Series A (Mar 26, 2020)
- Investors on record: 1

## About

Founded in 2019 and based in Shanghai, China, Hongyu Medical operates as a medical company that focuses on interventional cardiology treatment for pet dogs. It cooperated with several university veterinary hospitals around the world. In March 2020, Hongyu Medical raised a series A funding for CNY 30 million led by new investor CPE Funds Management.

Hongyu Medical mainly provides interventional cardiology treatment for pet dogs. Its products include the self-developed mitral valve interventional repair device V-Clamp and PMS Pet Health Monitoring System. The product technology of V-Clamp came from the parent company Shanghai Hanyu Medical Technology. V-Clamp's catheter is only 6F or 14F, with repeatable clamping, adjustable clamping and more. Products have entered the clinical application stage in more than 30 countries, including the United States, the United Kingdom, France, Germany, and Japan.

The company generates revenue by providing interventional cardiology treatment for pet dogs.

## Funding rounds

- Series A, Mar 26, 2020, $4.2M — CPE Funds Management

## Investors

- CPE Funds Management (https://capitalatlas.ai/funds/cpe-funds-management) — Series A